These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32498023)

  • 1. Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.
    Deslée G; Zysman M; Burgel PR; Perez T; Boyer L; Gonzalez J; Roche N;
    Respir Med Res; 2020 Nov; 78():100764. PubMed ID: 32498023
    [No Abstract]   [Full Text] [Related]  

  • 2. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions.
    Laires PA; Nunes C
    Acta Med Port; 2020 Nov; 33(11):720-725. PubMed ID: 32707029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Ferguson J; Rosser JI; Quintero O; Scott J; Subramanian A; Gumma M; Rogers A; Kappagoda S
    Emerg Infect Dis; 2020 Aug; 26(8):1679-1685. PubMed ID: 32407284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.
    Wang L; Foer D; Bates DW; Boyce JA; Zhou L
    J Allergy Clin Immunol; 2020 Oct; 146(4):808-812. PubMed ID: 32735807
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
    Posso M; Comas M; Román M; Domingo L; Louro J; González C; Sala M; Anglès A; Cirera I; Cots F; Frías VM; Gea J; Güerri-Fernández R; Masclans JR; Noguès X; Vázquez O; Villar-García J; Horcajada JP; Pascual J; Castells X
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):756-758. PubMed ID: 32782092
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes and covid-19: more than the sum of two morbidities.
    Pititto BA; Ferreira SRG
    Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and COPD in Hospitalized COVID-19 Patients.
    García-Pachón E; Zamora-Molina L; Soler-Sempere MJ; Baeza-Martínez C; Grau-Delgado J; Padilla-Navas I; Gutiérrez F
    Arch Bronconeumol (Engl Ed); 2020 Sep; 56(9):604-606. PubMed ID: 32586704
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).
    Lippi G; Henry BM
    Respir Med; 2020 Jun; 167():105941. PubMed ID: 32421537
    [No Abstract]   [Full Text] [Related]  

  • 12. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.
    Gémes K; Talbäck M; Modig K; Ahlbom A; Berglund A; Feychting M; Matthews AA
    Eur J Epidemiol; 2020 May; 35(5):401-409. PubMed ID: 32424571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis.
    Javanmardi F; Keshavarzi A; Akbari A; Emami A; Pirbonyeh N
    PLoS One; 2020; 15(10):e0241265. PubMed ID: 33095835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
    Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
    Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How likely are COVID-19 interventions to benefit the sickest patients?
    Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
    Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Susceptibility in chronic obstructive pulmonary disease.
    Olloquequi J
    Eur J Clin Invest; 2020 Oct; 50(10):e13382. PubMed ID: 32780415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic.
    Kaye L; Theye B; Smeenk I; Gondalia R; Barrett MA; Stempel DA
    J Allergy Clin Immunol Pract; 2020; 8(7):2384-2385. PubMed ID: 32371047
    [No Abstract]   [Full Text] [Related]  

  • 19. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aerosolised medications at home for COVID-19.
    Ari A
    Lancet Respir Med; 2020 Aug; 8(8):754-756. PubMed ID: 32585138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.